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Objectives: Subjective memory complaints (SMC) are common in older people and previous research has shown an
association with mood problems, such as depression and anxiety. SMC form part of the criteria for many definitions of
mild cognitive impairment (MCI), but there is controversy over whether they should be included as they may be related
more strongly to mood than to objective cognitive impairment. This study aims to clarify the relationship between mood
and SMC in people with MCI.
Method: This paper reports an analysis of data from the Medical Research Council Cognitive Function and Ageing study.
Structured interviews were conducted with community-dwelling older people to assess a range of aspects of cognitive
functioning and mood. Data from two time points approximately 24 months apart were used in this analysis. At baseline,
participants without dementia or severe cognitive impairment were categorised into three groups according to cognitive
status. Mood was investigated by assessing symptoms of anxiety and depression which were defined using a diagnostic
algorithm. Associations were tested using logistic regression and chi square analyses.
Results: A clear association was shown between SMC and mood, both cross-sectionally and over time. The relationship
between our two competing definitions of MCI suggested that mood problems were more strongly related to the presence
of SMC than objective cognitive impairment.
Conclusion: SMC may be a function of anxiety and depression rather than being related to objective cognitive function.
This questions whether SMC should be included in definitions of MCI.
Keywords: depression; anxiety; cognitive impairment
Abbreviations
ADL: Activities of daily living
CAMCOG: Cambridge Cognitive Evaluation
CAMDEX: Cambridge Mental Disorders of the
Elderly Examination
GMS-AGECAT: Geriatric Mental State Automated
Geriatric Examination for Computer
Assisted Taxonomy
MCI: Mild cognitive impairment
MCIW: Mild cognitive impairment without
subjective memory complaints
MMSE: Mini-Mental State Exam
MRC-CFAS: Medical Research Council Cognitive
Function and Ageing Study
OCIND: Other cognitive impairment, no
dementia
OR: Odds ratio
SMC: Subjective memory complaints
Introduction
Subjective memory complaints (SMC) are reports of prob-
lems with, or changes in, memory and are common in
older people (Balash et al., 2013; Dux et al., 2008).
Assessments of SMC range from brief questions concern-
ing individuals’ perceived memory function or how mem-
ory changes may have affected activities of daily living
(ADL) (Cook & Marsiske, 2006) to more in-depth
questionnaires, such as the Memory Functioning Ques-
tionnaire (Gilewski, Zelinski, & Schaie, 1990) or the
Metamemory in Adulthood Questionnaire (Dixon,
Hultsch, & Hertzog, 1988). SMC are associated with a
lower quality of life in older people (Iliffe & Pealing,
2010; Mol, van Boxtel, Willems, & Jolles, 2006).
Petersen et al. (2001) make a connection between SMC
and mild cognitive impairment (MCI)  a concept devel-
oped to describe a transitional phase between age-appropri-
ate cognitive functioning and pathological decline
(Matthews, Stephan, McKeith, Bond, & Brayne, 2008).
However, this is controversial with other researchers sug-
gesting that SMC are not an essential criterion for MCI and
may lack both specificity and sensitivity as a diagnostic cri-
terion (Lenehan, Klekociuk, & Summers, 2012). Accord-
ingly, SMC are included as a criterion in only 10 of the 19
MCI definitions identified by the Medical Research Council
Cognitive Function and Ageing Study (MRC-CFAS) study
(Matthews et al., 2008; Stephan, Brayne, McKeith, Bond, &
Matthews, 2008) alongside the requirement for an objective
impairment in memory or other cognitive domains, such as
language, absence of dementia, intact general cognitive
functioning and intact ADL (Petersen, 2004; Petersen et al.,
2001; Petersen et al., 1999).
Including SMC as a criterion for classification of MCI
reduces the prevalence estimates of MCI (Matthews et al.,
2008), in that as many as 62% of individuals who experi-
ence cognitive decline do not report SMC (Iliffe &
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Pealing, 2010). Possible reasons for such a discrepancy
may include individual variations in adapting to cognitive
change, where some individuals may not perceive such
changes as significant or requiring action. However, pro-
gression to dementia in one study was predicted better by
the presence of memory complaints than by global cogni-
tive impairment without dementia or by domain-specific
cognitive impairments. Palmer, Backman, Winblad, and
Fratiglioni (2003) found that 51% of future dementia
cases in a sample drawn from a population-based study
had memory complaints.
SMC have also been related to depression and anxiety
(McDougall, Becker, & Arheart, 2006). Depression or anxi-
ety may influence the expression of SMC. Depression is
positively associated with SMC (Minett, Da Silva, Ortiz, &
Bertolucci, 2008; Zandi, 2004) and may enhance negative
attributions (Roberts, Clare, & Woods, 2009) so that indi-
viduals may experience a distorted subjective appraisal of
their memory function in the presence of depressive symp-
toms. SMCwithout objective impairment may be a manifes-
tation of depressive symptoms (Balash et al., 2013). An
increase in anxiety has also been associated with an increase
in SMC despite no decrease in objective memory perfor-
mance (Dux et al., 2008). Anxiety was found to be higher in
individuals with SMC who have lower Mini Mental State
Examination scores (MMSE) (Balash et al., 2013; Folstein,
Folstein, & McHugh, 1975). Symptoms of depression and
anxiety are increased in individuals who have been classi-
fied as having MCI (Barnes, Alexopoulos, Lopez, William-
son, & Yaffe, 2006; Bhalla et al., 2009; Chan, Kasper,
Black, & Rabins, 2003; Geda et al., 2006; Yates, Clare, &
Woods, 2013), potentially indicating a risk factor for the
development of MCI, a reaction to the onset of
cognitive decline or a circular relationship involving both
possibilities. Depression may also form part of a prodromal
phase of dementia, which would justify a triple relationship
between depression, SMC and cognitive decline (Minett et
al., 2008).
This study aimed to clarify the relationship
between mood and SMC in people with MCI, in order to
add to the discussion over whether SMC should be
included as a criterion in the MCI definition. Previous
research has established the association between SMC
and mood, but this study has contributed to the field by
investigating the role of SMC through their absence,
which is a novel approach, not previously applied to the
CFAS data-set.
This study aimed to answer the following research
questions.
(1) Are people with MCI more likely to have symp-
toms of anxiety or depression than people with
normal cognitive functioning?
(2) Are people with SMC more likely to report symp-
toms of anxiety or depression than people without
SMC?
(3) Does anxiety or depression at baseline predict the
presence of SMC two years later?
(4) Is anxiety or depression at baseline associated
with a change in cognitive status over two years?
(5) Will a change in cognitive status over two years
predict the presence of anxiety or depression at
the end of the two-year period?
Methods
Design
Mood and the presence of SMC were assessed longitudi-
nally in a sample of community-dwelling older people who
were participating in the MRC-CFAS. MRC-CFAS is a lon-
gitudinal population-based study involving participants
drawn from five centres which represent rural and urban
areas of England and Wales, investigating changes that
affect people as they age. Participants were initially
screened regarding their general health and day-to-day
activities. Twenty per cent of the sample, including all those
with apparent cognitive impairment on a screening measure
and a proportion of other participants (randomly selected,
stratified for age, geographical location and gender) went on
to complete a more detailed assessment. Initial screening
took place during 19911993. Participants were assessed
again after approximately 24 months, between 1993 and
1995. Ethical approval was granted by University and NHS
Ethics Committees and participants provided fully informed
consent before taking part. This paper presents the analysis
of baseline and follow-up data. The analyses reported in this
paper were conducted in 2014.
Participants
Individuals over 65 years and living in the Gwynedd,
Cambridge, Nottinghamshire, Newcastle and Oxford
areas of the United Kingdom were randomly sampled
from 1990 to 1991. Fuller details are reported elsewhere
(Brayne, McCracken, Matthews, & MRC-CFAS, 2006).
The participants investigated in this study consisted of the
20% subsample who took part in the detailed assessment,
drawn from the larger baseline sample. Data from the first
assessment and two-year follow up interviews were used
in this analysis. Participants were excluded from analyses
if they had objective cognitive impairment beyond the cri-
teria for MCI [dementia n D 587; other cognitive
impairment, no dementia (OCIND) n D 234] or impaired
ADLs (n D 475) resulting in 1344 participants included at
the first assessment and 896 participants included at the
two-year follow-up.
Definition of subjective memory complaints
SMC were indicated by a self-report of memory problems
by the participant. This was assessed using two questions
from the baseline screening interview, ‘Have you ever
had difficulty with your memory?’ and ‘Have you tended
to forget things recently?’, and one question from the
combined screen and interview ‘Have you had any diffi-
culty with your memory?’ A positive answer to any of the
above questions resulted in a participant being categorised
as having an SMC at baseline, with SMC being a dichoto-
mous category. SMC at follow-up were identified by a
positive answer to either of two questions from the
2 J.A. Yates et al.
D
ow
nl
oa
de
d 
by
 [B
an
go
r U
niv
ers
ity
] a
t 0
2:2
1 0
7 J
an
ua
ry
 20
16
 
assessment: ‘Have you had any difficulty with your mem-
ory?’ or ‘Have you tended to forget things recently?’
Again, SMC was a dichotomous category.
Assessment of mood
Anxiety and depression were defined by the Geriatric Men-
tal State Automated Geriatric Examination for Computer
Assisted Taxonomy (GMS-AGECAT) (Copeland, Dewey,
& Griffiths-Jones, 1986) algorithm, which was calculated
from questions asked during the MRC-CFAS interview
(http://www.cfas.ac.uk). Traditionally, a GMS-AGECAT
score of two indicates a subcase and a score of three or
above indicates a case of anxiety or depression. In this
study, participants with scores of two and above for anxiety
or depression were considered to be a case in order to
account for borderline and milder symptoms.
Classification of cognitive status
Several cognitive status categories are referred to through-
out this study and were used to classify individuals at vari-
ous points along the continuum from normal ageing to
dementia. An algorithm was used to allocate participants to
each cognitive status category (Figure 1). MCI was a broad
definition using criteria similar to Petersen (Petersen et al.,
START
Dementia
(AGECAT score of O3 or higher)
Objective memory or non-memory 
cognitive impairment
(below age adjusted norms on CAMCOG)
YESNO Categorised as dementia 
NO YES
Categorised as no cognitive 
impairment (NCI) 
Subjective memory complaint
NO
YES
Categorised as mild cognitive 
impairment-without (MCIW) 
Intact general cognition
(score ≥ 22 on MMSE)
NO
YES
Categorised as impaired 
ADLs (ADL)
Intact activities of daily living (ADLs)
Categorised other cognitive 
impairment (OCIND) 
NO YES
Categorised as mild cognitive 
impairment (MCI)
Figure 1. Algorithm used to allocate participants to each cognitive status category.
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1999), where participants categorised as MCI had an
objective cognitive impairment (defined as a CAMDEX
Cambridge Cognitive Examination score falling one stan-
dard deviation below age-adjusted norms), no dementia
(shown as an AGECAT score of below O3), intact ADLs
(defined using questions asked within the MRC-CFAS inter-
view), intact general cognitive function (indicated by a score
of 22 or higher on the MMSE) and SMC. The criterion of
intact general cognition was included in order to maintain
similarity in the MCI definition used with other studies that
have used data from CFAS I.
A further cognitive status category was used at base-
line which included participants who met all the criteria
for MCI, except that they did not report SMC: these were
described as MCI-without (MCIW; see Figure 1).
At follow-up, participants could be categorised as hav-
ing MCI, MCIW, or dementia, or could be classified in
two further categories (Figure 1). Some participants were
classified as having other cognitive impairment, no
dementia (OCIND) which comprised individuals who had
general cognitive decline (defined by an MMSE score as
lower than 22), but did not meet criteria for dementia and
had intact ADLs. This group included participants with
and without SMC. Participants could also be classified in
the ADL category, which included people who had gen-
eral cognitive decline (defined by an MMSE score of less
than 22), impairments in ADLs but did not meet criteria
for dementia. Again, this category included participants
with and without SMC.
Statistical analyses
Analyses were conducted using SPSS 20.0. Differences
between participants with and without SMC were
described for both time points. Logistic regression was
used to calculate odds ratios (OR) for symptoms of
anxiety or depression at baseline and follow-up accord-
ing to cognitive status and presence of SMC. Pearson’s
chi-squared test was used to calculate changes in the
presence of SMC and changes in cognitive status in
the presence of symptoms of anxiety and depression
over two years.
Results
Table 1 summarises the characteristics of the study sam-
ple at baseline and follow-up according to whether SMC
were reported. At baseline, 557 participants from a total
of 1344 (41.4%) participants reported SMC. There did not
appear to be differences between those with SMC and
those without in terms of age, MMSE scores, years in full
time education or gender. Table 2 summarises the cogni-
tive status of the participants according to whether or not
SMC were reported. Due to the definitions used to create
the cognitive classifications, all participants classified as
having MCI reported SMC, and none of the participants
classified as having MCIW reported SMC. The cognitive
status of some participants changed between baseline and
follow-up and this is shown in Figure 2. According to the
definitions for cognitive impairment used in this study,
49.5% of participants were classified as having MCI or
MCIW at baseline and 28.6% of participants were classi-
fied as having MCI or MCIW at follow-up.
Logistic regressions were conducted for each cogni-
tive status group at baseline to investigate the odds of the
presence of symptoms of anxiety or depression and results
are shown in Table 3. The odds of having symptoms of
anxiety or depression at baseline were significantly
increased in participants classified as having MCI but
were significantly decreased in those classified as MCIW
relative to participants without cognitive impairment. The
odds of having symptoms of anxiety at follow-up were
not significantly increased or decreased for any cognitive
status at baseline; however, the odds of having symptoms
of depression at follow-up were increased in participants
classified as having MCI relative to participants without
cognitive impairment.
Logistic regressions were conducted to determine the
odds of symptoms of anxiety or depression at follow-up
and results are shown in Table 3. The odds of having
symptoms of anxiety at follow-up were significantly
increased for participants in the ADL category, and for
depression in the MCI and ADL categories, relative to
participants without cognitive impairment.
Logistic regression using the baseline data showed
that the odds of having symptoms of anxiety or depression
Table 1. Sample characteristics for participants with and without subjective memory complaints at baseline and follow-up.
Baseline Follow-up
No SMC SMC No SMC SMC
Age mean (sd) 73.69 (6.15) 74.56 (6.50) 75.41 (6.17) 76.68 (6.62)
MMSE mean (sd) 25.13 (3.69) 24.86 (3.49) 25.40 (3.47) 25.07 (3.13)
Female N (%) 501 (63.7) 360 (64.6) 433 (65.7) 151 (63.7)
Years in FT education mean (sd) 9.86 (2.13) 10.03 (2.23) 9.98 (2.12) 10.12 (2.32)
Without depression (%) 629 (79.9) 370 (66.4) 546 (82.9) 141 (59.5)
With depression (%) 158 (20.1) 187 (33.6) 113 (17.1) 96 (40.5)
Without anxiety (%) 766 (97.3) 514 (92.3) 651 (98.8) 214 (90.3)
With anxiety (%) 21 (2.7) 43 (7.7) 8 (1.2) 23 (9.7)
Total (%) 787 (58.6) 557 (41.4) 659 (73.5) 237 (26.5)
4 J.A. Yates et al.
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were higher in participants who reported SMC compared
to those who did not report SMC (anxiety: OR D 3.05, CI
D 1.795.20, p < .001; depression: OR D 2.01, CI D
1.572.58, p < .001).
A significant association was found between the pres-
ence of anxiety at baseline and the presence of SMC at
follow-up (x2 (1) D 12.56, p < .001). Based on the odds
ratio, having anxiety at baseline increased the odds of hav-
ing SMC at follow-up by a factor of 2.95. Partial correla-
tion showed that the relationship between anxiety at
baseline and SMC at follow-up remained significant when
anxiety at follow-up was controlled for [r D .66, p (one-
tailed) D .025] with anxiety at baseline accounting for
44% of the variance in SMC at follow-up. The association
between the presence of depression at baseline and the
presence of SMC at follow-up was also significant (x2 (1)
D 18.01, p < .001). Having depression at baseline
increased the odds of having SMC at follow-up by a factor
of 2.00 according to the odds ratio. Partial correlation
showed that the relationship between depression at base-
line and SMC at follow-up was significant when depres-
sion at follow-up was controlled for, with depression at
baseline accounting for 41% of the variation in SMC at
follow-up [r D .064, p (one tailed) D .027].
A significant association was found between the pres-
ence of anxiety at follow-up and the presence of SMC at
follow-up (x2 (1) D 37.62, p < .001). Based on the odds
ratio, having anxiety at follow-up increased the odds of
having SMC at follow-up by a factor of 8.75. The associa-
tion between the presence of depression at follow-up
and the presence of SMC at follow-up was also significant
(x2 (1) D 53.18, p < .001). This resulted in increased
odds of having SMC at follow-up by a factor of 3.29
when depression was present at follow-up.
The presence of symptoms of anxiety or depression at
baseline was not associated with progression from no
Table 2. Cognitive status according to SMC at baseline.
Baseline Follow-up
N(%) No SMC SMC No SMC SMC
NCI 399 (50.7) 280 (50.3) 360 (54.6) 94 (39.7)
MCI 0 (0.0) 277 (20.6) 0 (0.0) 61 (6.8)
MCIW 388 (49.3) 0 (0.0) 195 (29.6) 0 (0.0)
OCIND 35 (5.3) 15 (6.3)
ADL 47 (7.1) 39 (16.5)
Dementia 22 (3.3) 26 (11.0)
Total 787 (58.6) 557 (44.4) 659 (73.5) 237 (26.5)
NCID not cognitively impaired.
MCI D participants show objective cognitive impairment, intact general cognition, intact ADLs, no dementia, report of
SMC.
MCIW represents participants who would otherwise be classified as MCI but do not report an SMC.
OCINDD other cognitive impairment, no dementia where participants indicate general cognitive decline but have intact
ADLs and do not meet criteria for dementia.
ADLD participants who show general cognitive decline and impaired ADLs but do not meet criteria for dementia.
Dementia D participants who have been classified as having dementia.
Figure 2. Changes in cognitive status between baseline and follow-up. Baseline category is shown on the Y-axis and each bar shows the
percentage of participants who have moved to each category at follow-up.
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cognitive impairment to MCI, OCIND, MCIW or demen-
tia, or from MCI to dementia, over two years (see
Table 4).
Symptoms of anxiety at follow-up were not associated
with a change in cognitive status from no cognitive
impairment to MCI, OCIND, MCIW or dementia, or from
MCI to dementia, over two years. Symptoms of depres-
sion at follow-up were associated with a change in cogni-
tive status from not cognitively impaired to a
classification of MCI between baseline and follow-up
(x2 (1) D 9.72, p D .002) resulting in an increase in odds
by a factor of four. However, symptoms of depression at
follow-up were not associated with a change in cognitive
status from no cognitive impairment to OCIND, MCIW
or dementia, or from MCI to dementia, over two years
(see Table 4). Depression at baseline and anxiety and
depression at follow-up were associated with an increase
in risk of developing ADL impairment in those with no
cognitive impairment at baseline.
Discussion
This study aimed to clarify the relationship between mood
and SMC in people with MCI, in order to understand their
Table 3. Logistic regressions to show odds of anxiety or
depression dependent on cognitive status.
Baseline cognitive status
Anxiety at baseline OR CI P
NCI 0.75 0.451.25 .268
MCI 3.22 1.935.38 .000
MCIW 0.34 0.160.72 .005
Depression at baseline
NCI 1.04 0.821.33 .736
MCI 1.71 1.282.27 .000
MCIW 0.58 0.440.78 .000
Anxiety at follow-up
NCI 0.90 0.441.85 .775
MCI 1.64 0.743.62 .224
MCIW 0.69 0.281.71 .423
Depression at follow-up
NCI 0.82 0.601.11 .198
MCI 1.87 1.302.67 .001
MCIW 0.72 0.501.05 .089
Follow-up cognitive status
Anxiety at follow-up
NCI 0.52 0.251.10 .086
MCI 1.49 0.445.05 .521
MCIW 0.24 0.061.02 .052
Dementia 1.23 0.295.31 .783
OCIND 0.00 0.00 .997
ADL 7.84 3.6916.63 .000
Depression at follow-up
NCI 0.54 0.390.74 .000
MCI 2.28 1.333.91 .003
MCIW 0.72 0.481.07 .105
Dementia 1.10 0.562.16 .778
OCIND 1.59 0.862.95 .139
ADL 2.96 1.874.68 .000
NCI D not cognitively impaired.
MCI D participants show objective cognitive impairment, intact general
cognition, intact ADLs, no dementia, report of SMC
MCIW represents participants who would otherwise be classified as MCI
but do not report an SMC.
OCINDD other cognitive impairment, no dementia where participants
indicate general cognitive decline but have intact ADLs and do not meet
criteria for dementia.
ADLD participants who show general cognitive decline and impaired
ADLs but do not meet criteria for dementia.
DementiaD participants who have been classified as having dementia.
Significant at p D .05 level, Significant at p < .001 level.
Table 4. Associations between symptoms of anxiety or depres-
sion and changes in cognitive status over two years.
Pearson chi square p
Anxiety at baseline
Baseline Follow-up
NCI MCI 0.14 .710
NCI MCIW 0.52 .470
NCI Dementia 0.37 .544
NCI OCIND 0.56 .453
NCI ADL 2.02 .155
MCI Dementia 0.50 .480
MCIW Dementia 0.36 .549
Depression at baseline
Baseline Follow-up
NCI MCI 0.02 .902
NCI MCIW 0.27 .603
NCI Dementia 0.01 .913
NCI OCIND 0.17 .681
NCI ADL 10.42 .001
MCI Dementia 0.38 .537
MCIW Dementia 0.46 .499
Anxiety at follow-up
Baseline Follow-up
NCI MCI 0.19 .664
NCI MCIW 2.12 .146
NCI Dementia 0.56 .452
NCI OCIND 0.49 .483
NCI ADL 21.61 .000
MCI Dementia 0.04 .851
MCIW Dementia 1.03 .310
Depression at follow-up
Baseline Follow-up
NCI MCI 9.88 .002
NCI MCIW 2.91 .088
NCI Dementia 0.82 .366
NCI OCIND 0.00 .984
NCI ADL 18.98 .000
MCI Dementia 0.11 .743
MCIW Dementia 2.06 .151
NCI D not cognitively impaired.
MCI D participants show objective cognitive impairment, intact general
cognition, intact ADLs, no dementia, report of SMC.
MCIW represents participants who would otherwise be classified as MCI
but do not report an SMC.
OCINDD other cognitive impairment, no dementia where participants
indicate general cognitive decline but have intact ADLs and do not meet
criteria for dementia.
ADLD participants who show general cognitive decline and impaired
ADLs but do not meet criteria for dementia.
DementiaD participants who have been classified as having dementia.
Significant at p D .05 level, Significant at p < .001 level.
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appropriateness as a criterion in the MCI definition and
add to the growing discussion around this. This study has
used a novel approach to investigating the role of SMC by
directly comparing their presence or absence in people
who would otherwise meet criteria for MCI. The odds of
having symptoms of anxiety or depression were increased
in people with MCI compared to those without cognitive
impairment or categorised as MCIW, but increases in
odds were not seen for participants classified as MCIW.
Logistic regression also indicated that the odds of report-
ing symptoms of anxiety or depression are increased in
participants with SMC compared with participants with-
out. Symptoms of anxiety and depression at baseline were
significantly associated with the presence of SMC at fol-
low-up but were not associated with a change in cognitive
status between baseline and follow-up. Symptoms of
depression at follow-up were significantly associated with
a change in cognitive status from not cognitively impaired
to a classification of MCI over two years, but symptoms
of anxiety at follow-up did not show such an association.
The finding that people classified as having MCI have
increased odds of experiencing symptoms of anxiety or
depression compared to people without cognitive
impairment is in line with the previous literature which
has suggested that anxiety and depression are common
comorbidities of MCI (Kruger et al., 2012; Ravaglia et al.,
2008; Van der Linde, Stephan, Matthews, Brayne, &
Savva, 2010). However, the odds of having symptoms of
anxiety or depression are not increased in people classi-
fied as MCIW. This might suggest that the increase in
odds for people with MCI is related to the SMC compo-
nent of the MCI definition, as SMC are not a requirement
for the MCIW category. Other research (Cook & Marsiske,
2006) suggests that depression does not drive the relation-
ship between subjective beliefs and objective cognitive per-
formance. However, no participants in the study by Cook
and Marsiske (2006) endorsed depressive symptoms to a
clinical level, whereas this study includes participants with
clinical levels of depressive symptoms.
The odds of reporting symptoms of anxiety or depres-
sion are increased in participants reporting SMC com-
pared to participants who did not report SMC. Again, this
is in line with the previous literature (Balash et al., 2013;
Caselli et al., 2013; Dux et al., 2008; Minett et al., 2008;
Schmand, Jonker, Geerlings, & Lindeboom, 1997) and
suggests that SMC and symptoms of anxiety or depression
are related.
Data from two time points were used to investigate the
relationship between SMC and symptoms of anxiety or
depression over time, and participants who reported both
anxiety and depression at baseline were more likely to
have SMC two years later even after anxiety and depres-
sion at follow-up was controlled for. This suggests that
anxious or depressive symptomology could influence how
an individual appraises their memory or cognitive
abilities, a possibility that has also been considered by
other researchers (Dux et al., 2008; Jorm et al., 1997;
Roberts et al., 2009).
Symptoms of anxiety and depression at baseline and
anxiety at follow-up were not associated with changes in
cognitive status between baseline and follow-up for either
type of cognitive impairment (MCI or MCIW), with
changes from normal cognitive functioning to dementia,
or with changes from MCI to dementia. Symptoms of
depression at follow-up were only associated with a
change from not cognitively impaired to a classification
of MCI. This contradicts previous research which has
found that anxiety and depression are risk factors for cog-
nitive decline (Caracciolo, Backman, Monastero, Win-
blad, & Fratiglioni, 2011; Geda et al., 2006; Goveas,
Espeland, Woods, Wassertheil-Smoller, & Kotchen,
2011) but supports other research which has found that
anxiety and depression may not be risk factors for pro-
gression from MCI to dementia (Gallagher et al., 2011;
Vicini Chilovi et al., 2009).
Limitations of this study include the loss of partici-
pants at follow-up, leading to a relatively small number of
participants reporting symptoms of anxiety at follow-up.
Only data from participants who took part at both time
points were used when assessing changes over the two-
year period. Participants left the study between baseline
and follow-up for several reasons, such as moving away
from the study area, elective withdrawal and death.
Two years may not be enough time to track develop-
ment of cognitive decline, SMC, or the development of
symptoms of anxiety or depression. However, studies
with longer follow-up periods have reported similar
results (Comijs, Deeg, Dik, Twisk, & Jonker, 2002; Jorm
et al., 1997).
Although the definitions of cognitive impairment used
in this study rely on a participant’s performance on an
objective cognitive task, participants did not necessarily
progress from no cognitive impairment to a type of cogni-
tive impairment in a straightforward direction. The results
show that 18.8% of participants classified as MCI and
21.6% of participants classified as having MCIW at base-
line are classified as having normal cognitive functioning
at follow-up, showing that many participants’ cognitive
performance had improved. This suggests that the catego-
ries of cognitive impairment used may lack stability. This
result can also be found in other longitudinal studies
(Palmer, Wang, B€ackman, Winblad, & Fratiglioni, 2002;
Ritchie, Aterero, & Touchon, 2001) using a similar time
frame to this study. The variable progression in MCI pro-
vides further evidence for the heterogeneous nature of
MCI (DeCarli, 2003). Presence of SMC was also found to
be unstable, with 38.1% of participants who had reported
them at baseline no longer reporting them at follow-up.
Cognitive performance, SMC and symptoms of anxi-
ety and depression were recorded as categorical data. A
longer validated measure of SMC would have been prefer-
able, and the items used did not cover all aspects. This
does not allow for investigations into the variance that
exists in cognitive performance and in mood-related expe-
rience and mediation or moderation analyses could not be
performed.
Despite these possible limitations, this study has
several strengths: the Cambridge Cognitive Examination
(CAMCOG), is well established as a cognitive assessment
tool for dementia and milder levels of cognitive
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impairment, and has been widely used in this area of
research. The criteria used to create the MCI classification
here are consistent with established definitions of MCI
(Petersen, 2004; Petersen et al., 2001; Petersen et al.,
1999). The procedure for assessment of mood-related
symptoms used in this study has also previously been
used to produce prevalence calculations for anxiety and
depression which are in line with previous research and
can be considered to be robust (Van der Linde et al.,
2010). Lastly, this study uses a subsample drawn from a
larger population sample, which is representative of the
older population as participants were not identified
through attendance at health services.
Conclusions
This study has shown that people classified as having MCI
are more likely to report symptoms of anxiety and depres-
sion people without cognitive impairment. Interestingly,
participants in the MCIW group, who did not report SMC,
were less likely than those without cognitive impairment
to report anxiety and depression. People who reported
SMC were more likely to also report mood problems
regardless of their cognitive status. Participants who
reported anxiety or depression at baseline were more
likely to report SMC at the follow-up time point, but anxi-
ety and depression at baseline were not associated with a
change in cognitive status over two years. Only the pres-
ence of depression at the follow-up time point was associ-
ated with a change from not cognitively impaired to a
classification of MCI.
The findings of this study also imply that a large num-
ber of participants who would otherwise meet criteria for
MCI are missed, if SMC are seen as an essential criterion,
and so may not receive appropriate support. Memory clin-
ics can provide support, and access to interventions to
improve memory and cognitive functioning, and can be
provided upon referral from general practitioners. How-
ever, people who do not report memory problems are
unlikely to seek such a referral, their objective cognitive
problems are likely to remain unnoticed, and support that
may benefit them in the long term is likely to remain inac-
cessible. More attention may also be needed for anxiety
and depression in the context of MCI. This study suggests
that SMC contribute significantly to the relationship
between MCI and mood.
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